Prevention of surgical site infections in orthopaedic surgery and bone trauma: State-of-the-art update

Journal of Hospital Infection

Volumn 84, Issue 1, 2013, Pages 5-12

  Uckay I ^a   Hoffmeyer, P ^a   Lew, D ^a   Pittet, D ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Antibiotic prophylaxis; Bone trauma; Multimodal approach; Orthopaedic; Prevention; Surgical site infection

Indexed keywords

CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; GLUCOSE; PSEUDOMONIC ACID; TEICOPLANIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTISEPSIS; BACTERIAL COLONIZATION; BACTERIAL LOAD; BATH; BONE INJURY; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DEBRIDEMENT; DIABETES MELLITUS; DRUG EFFICACY; ELBOW ARTHROPLASTY; ESTHETIC SURGERY; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HEALTHCARE ASSOCIATED INFECTION; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; LAMINAR AIRFLOW; MALNUTRITION; META ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; ORTHOPEDIC SURGERY; OSTEOSYNTHESIS; PATIENT SAFETY; POSTOPERATIVE CARE; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURGICAL INFECTION; SURGICAL MORTALITY; SYSTEMATIC REVIEW; VACUUM ASSISTED CLOSURE; WOUND CARE;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; EVIDENCE-BASED PRACTICE; FRACTURES, BONE; GRAM-NEGATIVE BACTERIA; HUMANS; ORTHOPEDICS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 84876303088     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.12.014     Document Type: Review

References (80)

1. Rioux C., Grandbastien B., Astagneau P. The standardized incidence ratio as a reliable tool for surgical site infection surveillance. Infect Control Hosp Epidemiol 2006, 27:817-824.
2. Whitehouse J.D., Friedman N.D., Kirkland K.B., Richardson W.J., Sexton D.J. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002, 23:183-189.
3. Teterycz D., Ferry T., Lew D., et al. Outcome of orthopedic implant infections due to different staphylococci. Int J Infect Dis 2010, 14:913-918.
4. Uçkay I., Harbarth S., Peter R., Lew D., Hoffmeyer P., Pittet D. Preventing surgical site infections. Expert Rev Anti Infect Ther 2010, 8:657-670.
5. Uçkay I., Pittet D., Vaudaux P., Sax H., Lew D., Waldvogel F. Foreign body infections due to Staphylococcus epidermidis. Ann Med 2009, 41:109-119.
6. Uçkay I., Lübbeke A., Emonet S., et al. Low incidence of haematogenous seeding to total hip and knee prostheses in patients with remote infections. J Infect 2009, 59:337-345.
7. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., Jarvis W.R. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999, 20:250-278.
8. Anonymous National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004. Am J Infect Control 2004, 32:470-485.
9. Uçkay I., Harbarth S., Ferry T., et al. Meticillin resistance in orthopaedic coagulase-negative staphylococcal infections. J Hosp Infect 2011, 79:248-253.
10. Hanssen A.D., Osmon D.R., Nelson C.L. Prevention of deep periprosthetic joint infection. Instr Course Lect 1997, 46:555-567.
11. Prevention and treatment of surgical site infection. Guideline CG74 2008, National Institute for Health and Clinical Excellence, NICE, London.
12. Widmer A.F., Rotter M., Voss A., et al. Surgical hand preparation: state-of-the-art. J Hosp Infect 2010, 74:112-122.
13. Meehan J., Jamali A.A., Nguyen H. Prophylactic antibiotics in hip and knee arthroplasty. J Bone Joint Surg Am 2009, 91:2480-2490.
14. Prokuski L. Prophylactic antibiotics in orthopaedic surgery. J Am Acad Orthop Surg 2008, 16:283-293.
15. Tanner J., Swarbrook S., Stuart J. Surgical hand antisepsis to reduce surgical site infection. Cochrane Database Syst Rev 2008, 1. CD004288.
16. Dharan S., Pittet D. Environmental controls in operating theatres. J Hosp Infect 2002, 51:79-84.
17. Matar W.Y., Jafari S.M., Restrepo C., Austin M., Purtill J.J., Parvizi J. Preventing infection in total joint arthroplasty. J Bone Joint Surg Am 2010, 92:36-46.
18. Gatell J.M., Garcia S., Lozano L., Soriano E., Ramon R., SanMihuel J.G. Perioperative cefamandole prophylaxis against infections. J Bone Joint Surg Am 1987, 69:1189-1193.
19. Slobogean G.P., Kennedy S.A., Davidson D., O'Brien P.J. Single-versus multiple-dose antibiotic prophylaxis in the surgical treatment of closed fractures: a meta-analysis. J Orthop Trauma 2008, 22:264-269.
20. Evans R.P. Surgical site infection prevention and control: an emerging paradigm. J Bone Joint Surg Am 2009, 91:2-9.
21. Mini E., Nobili S., Periti P. Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis?. Drugs 1997, 54:39-52.
22. Cranny G., Elliott R., Weatherly H., et al. A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery. Health Technol Assess 2008, 12:1-168.
23. Uçkay I., Sax H., Harbarth S., Bernard L., Pittet D. Multi-resistant infections in repatriated patients after natural disasters: lessons learned from the 2004 tsunami for hospital infection control. J Hosp Infect 2008, 68:1-8.
24. Seghrouchni K., van Delden C., Dominguez D., et al. Remission after treatment of osteoarticular infections due to Pseudomonas aeruginosa versus Staphylococcus aureus: a case-controlled study. Int Orthop 2012, 36:1065-1071.
25. Uçkay I., Bernard L. Gram-negative versus gram-positive prosthetic joint infections. Clin Infect Dis 2010, 50:795-796.
26. Vergidis P., Lesnick T.G., Kremers W.K., Razonable R.R. Prosthetic joint infection in solid organ transplant recipients: a retrospective case-control study. Transpl Infect Dis 2012, 14:380-386.
27. Engesaeter L.B., Espehaug B., Lie S.A., Furnes O., Havelin L.I. Does cement increase the risk of infection in primary total hip arthroplasty? Revision rates in 56,275 cemented and uncemented primary THAs followed for 0-16 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2006, 77:351-358.
28. Jamsen E., Huhtala H., Puolakka T., Moilanen T. Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am 2009, 91:38-47.
29. Parvizi J., Saleh K.J., Ragland P.S., Pour A.E., Mont M.A. Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop Scand 2008, 79:335-341.
30. Josefsson G., Lindberg L., Wiklander B. Systemic antibiotics and gentamicin-containing bone cement in the prophylaxis of postoperative infections in total hip arthroplasty. Clin Orthop Relat Res 1981, 159:194-200.
31. Chiu F.Y., Chen C.M., Lin C.F., Lo W.H. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg Am 2002, 84:759-762.
32. Gustilo R.B., Anderson J.T. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am 1976, 58:453-458.
33. Hauser C.J., Adams C.A., Eachempati S.R. Surgical Infection Society guideline: prophylactic antibiotic use in open fractures: an evidence-based guideline. Surg Infect (Larchmt) 2006, 7:379-405.
34. Barie P.S. Breaking with tradition: evidence-based antibiotic prophylaxis of open fractures. Surg Infect (Larchmt) 2006, 7:327-329.
35. Dunkel N, Uçkay I, Macedo M, Pittet D. Short duration of antibiotic prophylaxis in Gustilo grade III open extremities fractures does not enhance risk of subsequent infection. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, September 2010 (Abstract). In press.
36. Dellinger E.P., Caplan E.S., Weaver L.D., et al. Duration of preventive antibiotic administration for open extremity fractures. Arch Surg 1988, 123:333-339.
37. Stannard J.P., Volgas D.A., Stewart R., McGwin G., Alonso J.E. Negative pressure wound therapy after severe open fractures: a prospective randomized study. J Orthop Trauma 2009, 23:552-557.
38. Gosselin R.A., Roberts I., Gillespie W.J. Antibiotics for preventing infection in open limb fractures. Cochrane Database Syst Rev 2004, 1. CD003764.
39. Faisham W.I., Nordin S., Aidura M. Bacteriological study and its role in the management of open tibial fracture. Med J Malaysia 2001, 56:201-206.
40. Robinson D., On E., Hadas N., et al. Microbiologic flora contaminating open fractures: its significance in the choice of primary antibiotic agents and the likelihood of deep wound infection. J Orthop Trauma 1989, 3:283-286.
41. Uçkay I., Pittet D., Bernard L., Lew D., Perrier A., Peter R. Antibiotic prophylaxis before invasive dental procedures in patients with arthroplasties of the hip and knee. J Bone Joint Surg Br 2009, 90:833-838.
42. Berbari E.F., Osmon D.R., Carr A., et al. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis 2010, 50:8-16.
43. Browne J.A., Pietrobon R., Olson S.A. Hip fracture outcomes: does surgeon or hospital volume really matter?. J Trauma 2009, 66:809-814.
44. Saadatian-Elahi M., Teyssou R., Vanhems P. Staphylococcus aureus, the major pathogen in orthopaedic and cardiac surgical site infections: literature review. Int J Surg 2008, 6:238-245.
45. Haynes A.B., Weiser T.G., Berry W.R., et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 2009, 360:491-499.
46. De Lucas-Villarrubia J.C., Lopez-Franco M., Granizo J.J., De Lucas-Garcia J.C., Gomez-Barrena E. Strategy to control methicillin-resistant Staphylococcus aureus post-operative infection in orthopaedic surgery. Int Orthop 2004, 28:16-20.
47. Rao N., Cannella B., Crossett L.S., Yates A.J., McGough R. A preoperative decolonization protocol for Staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res 2008, 466:1343-1348.
48. Kalmeijer M.D., van Nieuwland-Bollen E., Bogaers-Hofman D., de Baere G.A. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 2000, 21:319-323.
49. Wilcox M.H., Hall J., Pike H., et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 2003, 54:196-201.
50. Gernaat-van der Sluis A.J., Hoogenboom-Verdegaal A.M., Edixhoven P.J., Spies-van Rooijen N.H. Prophylactic mupirocin could reduce orthopedic wound infections. 1,044 patients treated with mupirocin compared with 1,260 historical controls. Acta Orthop Scand 1998, 69:412-414.
51. Kim D.H., Spencer M., Davidson S.M., et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am 2010, 92:1820-1826.
52. Webster J., Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 2007, 2. CD004985.
53. Saltzman M.D., Nuber G.W., Gryzlo S.M., et al. Efficacy of surgical preparation solutions in shoulder surgery. J Bone Joint Surg Am 2009, 91:1949-1953.
54. Ostrander R.V., Botte M.J., Brage M.E. Efficacy of surgical preparation solutions in foot and ankle surgery. J Bone Joint Surg Am 2005, 87:980-985.
55. Darouiche R.O., Wall M.J., Itani K.M., et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010, 362:18-26.
56. Swenson B.R., Hedrick T.L., Metzger R., et al. Effects of preoperative skin preparation on postoperative wound infection rates: a prospective study of 3 skin preparation protocols. Infect Control Hosp Epidemiol 2009, 30:964-971.
57. Lee A.S., Macedo-Vinas M., Francois P., et al. Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital. J Hosp Infect 2011, 77:360-362.
58. Milstone A.M., Passaretti C.L., Perl T.M. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 2008, 46:274-281.
59. Tanner J., Parkinson H. Double gloving to reduce surgical cross-infection. Cochrane Database Syst Rev 2006, (3):CD003087.
60. Niel-Weise B.S., Wille J.C., van den Broek P.J. Hair removal policies in clean surgery: systematic review of randomized, controlled trials. Infect Control Hosp Epidemiol 2005, 26:923-928.
61. Maksimovic J., Markovic-Denic L., Bumbasirevic M., Marinkovic J., Vlajinac H. Surgical site infections in orthopedic patients: prospective cohort study. Croat Med J 2008, 49:58-65.
62. Lidwell O.M., Lowbury E.J., Whyte W., et al. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. BMJ 1982, 285:10-14.
63. Ritter M.A., Eitzen H.E., Hart J.B., French M.L. The surgeon's garb. Clin Orthop Relat Res 1980, 153:204-209.
64. Whyte W., Hodgson R., Tinkler J. The importance of airborne bacterial contamination of wounds. J Hosp Infect 1982, 3:123-135.
65. Evans R.P. Current concepts for clean air and total joint arthroplasty: laminar airflow and ultraviolet radiation: a systematic review. Clin Orthop Relat Res 2011, 469:945-953.
66. Hooper G.J., Rothwell A.G., Frampton C., Wyatt M.C. Does the use of laminar flow and space suits reduce early deep infection after total hip and knee replacement?: the ten-year results of the New Zealand Joint Registry. J Bone Joint Surg Br 2011, 91:85-90.
67. Brandt C., Hott U., Sohr D., et al. Operating room ventilation with laminar airflow shows no protective effect on the surgical site infection rate in orthopedic and abdominal surgery. Ann Surg 2008, 248:695-700.
68. Lowell J.D., Kundsin R.B., Schwartz C.M., Pozin D. Ultraviolet radiation and reduction of deep wound infection following hip and knee arthroplasty. Ann NY Acad Sci 1980, 353:285-293.
69. Ritter M.A., Olberding E.M., Malinzak R.A. Ultraviolet lighting during orthopaedic surgery and the rate of infection. J Bone Joint Surg Am 2007, 89:1935-1940.
70. Melling A.C., Ali B., Scott E.M., Leaper D.J. Effects of preoperative warming on the incidence of wound infection after clean surgery: randomised controlled trial. Lancet 2001, 358:876-880.
71. Karunakar M.A., Staples K.S. Does stress-induced hyperglycemia increase the risk of perioperative infectious complications in orthopaedic trauma patients?. J Orthop Trauma 2010, 24:752-756.
72. Lee-Smith J. Can the orthopaedic team reduce the risk of infection?. J Orthopaedic Nurs 1999, 3:95-98.
73. Woodhead K., Taylor E.W., Bannister G., Chesworth T., Hoffman P., Humphreys H. Behaviours and rituals in the operating theatre. J Hosp Infect 2002, 51:241-255.
74. Beldi G., Bisch-Knaden S., Banz V., et al. Impact of intraoperative behavior on surgical site infections. Am J Surg 2009, 198:157-162.
75. Douglas P., Asimus M., Swan J., Spigelman A. Prevention of orthopaedic wound infections: a quality improvement project. J Qual Clin Pract 2001, 21:149-153.
76. Cosker T., Elsayed S., Gupta S., et al. Choice of dressing has a major impact on blistering and healing outcomes in orthopaedic patients. J Wound Care 2005, 14:27-29.
77. Vermeulen H., Ubbink D., Goossens A., et al. Dressings and topical agents for surgical wounds healing by secondary intention. Cochrane Database Syst Rev 2004, (2):CD003554.
78. Shinohara T., Yamashita Y., Satoh K., et al. Prospective evaluation of occlusive hydrocolloid dressing versus conventional gauze dressing regarding the healing effect after abdominal operations: randomized controlled trial. Asian J Surg 2008, 31:1-5.
79. Ubbink D.T., Vermeulen H., Goossens A., et al. Occlusive vs gauze dressings for local wound care in surgical patients: a randomized clinical trial. Arch Surg 2008, 143:950-955.
80. Wynne R., Botti M., Stedman H., et al. Effect of three wound dressings on infection, healing comfort, and cost in patients with sternotomy wounds: a randomized trial. Chest 2004, 125:4349.